Abacavir hydroxyacetate

DB12187InvestigationalSmall moleculeHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Prurisol is under investigation for the treatment of Chronic Stable Plaque Psoriasis. Prurisol has been investigated for the treatment of Plaque Psoriasis.

Formula / weight: C₁₆H₂₀N₆O₃ · 344.375 g/mol (avg)

Resolves to

Compound

UNIIB3C7MG354BCAS1446418-48-9PubChem71605071

Structure

InChIKeyZBBZROWQLKCFQK-KOLCDFICSA-NSMILESNC1=NC(NC2CC2)=C2N=CN([C@@H]3C[C@H](COC(=O)CO)C=C3)C2=N1

What you can answer from here — as of April 02, 2025

3Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of Abacavir hydroxyacetate, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account